"Meridian Clinical Research studies the safety and efficacy of new treatments. When people like you participate in clinical trials, we can uncover better ways to treat conditions that may affect you and your loved ones. Meridian's Sioux City site conducts research for a broad range of investigational treatments. Studies at this site explore vaccines and medicines developed to treat migraines, acne, depression, high cholesterol, and other conditions."

During the past decade, Meridian Clinical Research conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 22 clinical trials were completed, i.e. on average, 95.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 16 clinical trials were completed. i.e. 320% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Meridian Clinical Research" #1 sponsor was "Pfizer" with 10 trials, followed by "ModernaTX, Inc." with 3 trials sponsored, "Dermira, Inc." with 2 trials sponsored, "Protein Sciences Corporation" with 2 trials sponsored and "Allergan" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Meridian Clinical Research" #1 collaborator was "Biomedical Advanced Research and Development Authority" with 2 trials as a collaborator, "Allergan Sales, LLC" with 1 trials as a collaborator, "Chattem, Inc." with 1 trials as a collaborator, "Children's Hospital Medical Center, Cincinnati" with 1 trials as a collaborator and "Department of Health and Human Services" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Meridian Clinical Research" are "Migraine, With or Without Aura" (3 trials), "Acne Vulgaris" (2 trials), "Fibromyalgia" (2 trials), "Influenza" (2 trials) and "Migraine" (2 trials). Many other conditions were trialed in "Meridian Clinical Research" in a lesser frequency.

Most popular intervention types in "Meridian Clinical Research" are "Drug" (18 trials), "Biological" (12 trials), "Other" (3 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Rimegepant" (4 trials), "13vPnC" (2 trials), "20vPnC" (2 trials) and "Olumacostat Glasaretil Gel, 5.0%" (2 trials). Other intervention names were less common.

The vast majority of trials in "Meridian Clinical Research" are 30 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Meridian Clinical Research". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Meridian Clinical Research, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Meridian Clinical Research, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".